Sichuan Hexie Shuangma Co., Ltd. (000935.SZ): Approval Granted for Market Launch of Acetate Leuprolide Chemical API

Stock News10-16

According to recent announcements, Sichuan Hexie Shuangma Co., Ltd. (000935.SZ) has received approval from the National Medical Products Administration for its subsidiary Hubei Jianxiang Bio-Pharmaceutical Co., Ltd. regarding the market launch of Acetate Leuprolide. The announcement indicates that Acetate Leuprolide is a Gonadotropin-Releasing Hormone (GnRH) agonist that effectively suppresses the secretion of gonadotropins when administered continuously at therapeutic doses. It has been approved domestically for the treatment of conditions including endometriosis, uterine fibroids, prostate cancer, estrogen receptor-positive premenopausal breast cancer, and central precocious puberty.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1170260896?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-16 15:48","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1170260896","market":"sh","top_or_hot":-1,"title":"Sichuan Hexie Shuangma Co., Ltd. (000935.SZ): Approval Granted for Market Launch of Acetate Leuprolide Chemical API","media":"Stock News","content":"<p>According to recent announcements, Sichuan Hexie Shuangma Co., Ltd. (000935.SZ) has received approval from the National Medical Products Administration for its subsidiary Hubei Jianxiang Bio-Pharmaceutical Co., Ltd. regarding the market launch of Acetate Leuprolide. The announcement indicates that Acetate Leuprolide is a Gonadotropin-Releasing Hormone (GnRH) agonist that effectively suppresses the secretion of gonadotropins when administered continuously at therapeutic doses. It has been approved domestically for the treatment of conditions including endometriosis, uterine fibroids, prostate cancer, estrogen receptor-positive premenopausal breast cancer, and central precocious puberty.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sichuan Hexie Shuangma Co., Ltd. (000935.SZ): Approval Granted for Market Launch of Acetate Leuprolide Chemical API</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSichuan Hexie Shuangma Co., Ltd. (000935.SZ): Approval Granted for Market Launch of Acetate Leuprolide Chemical API\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2025-10-16 15:48</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>According to recent announcements, Sichuan Hexie Shuangma Co., Ltd. (000935.SZ) has received approval from the National Medical Products Administration for its subsidiary Hubei Jianxiang Bio-Pharmaceutical Co., Ltd. regarding the market launch of Acetate Leuprolide. The announcement indicates that Acetate Leuprolide is a Gonadotropin-Releasing Hormone (GnRH) agonist that effectively suppresses the secretion of gonadotropins when administered continuously at therapeutic doses. It has been approved domestically for the treatment of conditions including endometriosis, uterine fibroids, prostate cancer, estrogen receptor-positive premenopausal breast cancer, and central precocious puberty.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0021","symbol_name":"外资并购(国际板)","start_time":0,"source_url":"","article_id":"1170260896","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1170260896","pubTimestamp":1760600890,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"According to recent announcements, Sichuan Hexie Shuangma Co., Ltd. (000935.SZ) has received approval from the National Medical Products Administration for its subsidiary Hubei Jianxiang...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK0021":"外资并购(国际板)","BK0235":"非金矿物","BK0028":"国家队","000935":"四川双马","BK0004":"股权转让"},"translate_title":"四川和谐双马股份有限公司（000935.SZ）：醋酸亮丙瑞林化学原料药获批上市","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"000935":1},"content_text":"According to recent announcements, Sichuan Hexie Shuangma Co., Ltd. (000935.SZ) has received approval from the National Medical Products Administration for its subsidiary Hubei Jianxiang Bio-Pharmaceutical Co., Ltd. regarding the market launch of Acetate Leuprolide. The announcement indicates that Acetate Leuprolide is a Gonadotropin-Releasing Hormone (GnRH) agonist that effectively suppresses the secretion of gonadotropins when administered continuously at therapeutic doses. It has been approved domestically for the treatment of conditions including endometriosis, uterine fibroids, prostate cancer, estrogen receptor-positive premenopausal breast cancer, and central precocious puberty.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1170260896","isCrawlerRequest":true}